• Topics

  • Immune-Mediated and Cholestatic Diseases
  • Public Health and Advocacy

Displaying results 37 - 47 of 47

Display:

12 24 48

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - EN

PDF

View

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - PL

PDF

View

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - PT

PDF

View

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - RO

PDF

View

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - RU

PDF

View

Public Health and Advocacy

EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

PDF

View

Public Health and Advocacy

EASL Policy Statement: Reducing alcohol harms

PDF

View

Public Health and Advocacy

EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues

View

Public Health and Advocacy

EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues

View

Public Health and Advocacy

EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues

View

Immune-Mediated and Cholestatic Diseases

EASL Studio S4 E7: Genetics in adult liver disease – missed opportunities?

EASL Studio

View

Displaying results 37 - 47 of 47

Display:

12 24 48